| dc.creator | Pérez Lloret, Santiago | |
| dc.creator | Rascol, Olivier | |
| dc.date.accessioned | 2020-01-29T20:51:35Z | |
| dc.date.accessioned | 2022-10-15T06:42:25Z | |
| dc.date.available | 2020-01-29T20:51:35Z | |
| dc.date.available | 2022-10-15T06:42:25Z | |
| dc.date.created | 2020-01-29T20:51:35Z | |
| dc.date.issued | 2012-07 | |
| dc.identifier | Pérez Lloret, Santiago; Rascol, Olivier; Parkinson disease: Serotonin reuptake inhibitors for depression in PD; Nature Publishing Group; Nature Reviews Neurology; 8; 7; 7-2012; 365-366 | |
| dc.identifier | 1759-4758 | |
| dc.identifier | http://hdl.handle.net/11336/96182 | |
| dc.identifier | CONICET Digital | |
| dc.identifier | CONICET | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/4356527 | |
| dc.description.abstract | A recent study to investigate the safety and efficacy of serotonin reuptake inhibitors suggests that these drugs are beneficial for the treatment of depressive disorders in Parkinson disease. Whether these treatments will offer such benefits in the long term compared with other pharmacological and nonpharmacological approaches remains to be determined. | |
| dc.language | eng | |
| dc.publisher | Nature Publishing Group | |
| dc.relation | info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/nrneurol.2012.111 | |
| dc.relation | info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1038/nrneurol.2012.111 | |
| dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | |
| dc.subject | enfermedad de parkinson | |
| dc.subject | antidepresivos | |
| dc.subject | depresión | |
| dc.title | Parkinson disease: Serotonin reuptake inhibitors for depression in PD | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
